IceCure Medical’s (ICCM) “Buy” Rating Reaffirmed at HC Wainwright

IceCure Medical (NASDAQ:ICCM)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a report issued on Wednesday,Benzinga reports. They presently have a $2.50 price objective on the stock. HC Wainwright’s price target would indicate a potential upside of 208.64% from the company’s previous close.

Separately, Alliance Global Partners raised IceCure Medical to a “strong-buy” rating in a research note on Friday, November 1st.

IceCure Medical Price Performance

IceCure Medical stock traded up $0.02 during mid-day trading on Wednesday, reaching $0.81. 160,944 shares of the company were exchanged, compared to its average volume of 580,506. IceCure Medical has a 12 month low of $0.48 and a 12 month high of $1.57. The company has a fifty day simple moving average of $0.64 and a 200-day simple moving average of $0.72. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.97 and a quick ratio of 2.54. The firm has a market cap of $36.95 million, a PE ratio of -2.73 and a beta of 0.48.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in IceCure Medical stock. Renaissance Technologies LLC acquired a new stake in shares of IceCure Medical Ltd (NASDAQ:ICCM) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 66,400 shares of the company’s stock, valued at approximately $49,000. Renaissance Technologies LLC owned approximately 0.15% of IceCure Medical as of its most recent filing with the SEC. 0.62% of the stock is owned by institutional investors and hedge funds.

About IceCure Medical

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.